NO20005586D0 - Genomiske sekvenser oppströms for den kodende regionen til G- CSF genet for produksjon og levering av protein - Google Patents

Genomiske sekvenser oppströms for den kodende regionen til G- CSF genet for produksjon og levering av protein

Info

Publication number
NO20005586D0
NO20005586D0 NO20005586A NO20005586A NO20005586D0 NO 20005586 D0 NO20005586 D0 NO 20005586D0 NO 20005586 A NO20005586 A NO 20005586A NO 20005586 A NO20005586 A NO 20005586A NO 20005586 D0 NO20005586 D0 NO 20005586D0
Authority
NO
Norway
Prior art keywords
delivery
coding region
protein production
genomic sequences
sequences upstream
Prior art date
Application number
NO20005586A
Other languages
English (en)
Other versions
NO20005586L (no
Inventor
Douglas A Treco
Michael W Heartlein
Richard F Selden
Original Assignee
Transkaryotic Therapies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transkaryotic Therapies Inc filed Critical Transkaryotic Therapies Inc
Publication of NO20005586D0 publication Critical patent/NO20005586D0/no
Publication of NO20005586L publication Critical patent/NO20005586L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/42—Vector systems having a special element relevant for transcription being an intron or intervening sequence for splicing and/or stability of RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/44—Vectors comprising a special translation-regulating system being a specific part of the splice mechanism, e.g. donor, acceptor
NO20005586A 1998-05-07 2000-11-06 Genomiske sekvenser oppströms for den kodende regionen til G- CSF genet for produksjon og levering av protein NO20005586L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8464998P 1998-05-07 1998-05-07
PCT/US1999/009924 WO1999057291A1 (en) 1998-05-07 1999-05-05 Genomic sequences upstream of the coding region of the g-csf gene for protein production and delivery

Publications (2)

Publication Number Publication Date
NO20005586D0 true NO20005586D0 (no) 2000-11-06
NO20005586L NO20005586L (no) 2001-01-03

Family

ID=22186313

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005586A NO20005586L (no) 1998-05-07 2000-11-06 Genomiske sekvenser oppströms for den kodende regionen til G- CSF genet for produksjon og levering av protein

Country Status (18)

Country Link
US (2) US6242218B1 (no)
EP (1) EP1075530A1 (no)
JP (1) JP2002513579A (no)
KR (1) KR20010071207A (no)
CN (1) CN1308680A (no)
AR (1) AR016263A1 (no)
AU (1) AU762969B2 (no)
CA (1) CA2328476A1 (no)
CZ (1) CZ299460B6 (no)
GC (1) GC0000172A (no)
HU (1) HUP0101355A3 (no)
IL (1) IL139431A0 (no)
NO (1) NO20005586L (no)
NZ (1) NZ507451A (no)
PL (1) PL344391A1 (no)
TR (1) TR200003272T2 (no)
WO (1) WO1999057291A1 (no)
ZA (1) ZA200005744B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001042442A2 (en) 1999-12-10 2001-06-14 Cytos Biotechnology Ag Activation of endogenous genes by genomic introduction of a replicon
JP2002017357A (ja) * 2000-07-04 2002-01-22 Calpis Co Ltd アンカーペプチド、融合蛋白質、及び蛋白質の固定化方法
US20030082511A1 (en) * 2001-09-25 2003-05-01 Brown Steven J. Identification of modulatory molecules using inducible promoters
EP1503788B1 (en) 2002-04-25 2011-06-29 Shire Human Genetic Therapies, Inc. Treatment of alpha-galactosidase a deficiency
AU2005211385B2 (en) 2004-02-02 2008-12-11 Ambrx, Inc. Modified human growth hormone polypeptides and their uses
RU2009141965A (ru) 2007-04-16 2011-05-27 Момента Фармасьютикалз, Инк. (Us) Определенные продукты гликопротеина и способы их производства
CA2685596A1 (en) 2007-05-02 2008-11-13 Ambrx, Inc. Modified interferon beta polypeptides and their uses
JP5702150B2 (ja) 2008-02-08 2015-04-15 アンブルックス, インコーポレイテッドAmbrx, Inc. 修飾されているレプチンポリペプチドおよびそれらの使用
EP2281050B1 (en) 2008-04-14 2014-04-02 Sangamo BioSciences, Inc. Linear donor constructs for targeted integration
JP5680534B2 (ja) 2008-07-23 2015-03-04 イーライ リリー アンド カンパニー 修飾されているウシｇ−ｃｓｆポリペプチドおよびそれらの使用
AR083006A1 (es) 2010-09-23 2013-01-23 Lilly Co Eli Formulaciones para el factor estimulante de colonias de granulocitos (g-csf) bovino y variantes de las mismas

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5968502A (en) 1991-11-05 1999-10-19 Transkaryotic Therapies, Inc. Protein production and protein delivery
US5641670A (en) * 1991-11-05 1997-06-24 Transkaryotic Therapies, Inc. Protein production and protein delivery

Also Published As

Publication number Publication date
HUP0101355A3 (en) 2003-08-28
EP1075530A1 (en) 2001-02-14
JP2002513579A (ja) 2002-05-14
US6242218B1 (en) 2001-06-05
AU3788799A (en) 1999-11-23
CN1308680A (zh) 2001-08-15
HUP0101355A2 (hu) 2001-08-28
KR20010071207A (ko) 2001-07-28
CA2328476A1 (en) 1999-11-11
ZA200005744B (en) 2001-05-16
AR016263A1 (es) 2001-06-20
AU762969B2 (en) 2003-07-10
WO1999057291A1 (en) 1999-11-11
CZ299460B6 (cs) 2008-08-06
CZ20003807A3 (cs) 2001-04-11
PL344391A1 (en) 2001-11-05
IL139431A0 (en) 2001-11-25
NZ507451A (en) 2003-12-19
TR200003272T2 (tr) 2001-03-21
NO20005586L (no) 2001-01-03
GC0000172A (en) 2006-03-29
US20030022850A1 (en) 2003-01-30

Similar Documents

Publication Publication Date Title
DE69917716D1 (de) Protein-deamiderendes Enzym, dafür kodierendes Gen, Verfahren zur Herstellung und Verwendung davon
DE60021160D1 (de) Protein-deamiderendes Enzym, dafür kodierendes Gen, enzym-produzierendes Mikroorganismus, Verfahren zur Herstellung und Verwendung davon
AU2003257009A8 (en) System and method for the distribution of digital products
NO20005586L (no) Genomiske sekvenser oppströms for den kodende regionen til G- CSF genet for produksjon og levering av protein
HUP0200480A3 (en) Enzymes of the biosynthetic pathway for the production of triacylglycerol and recombinant dna molecules encoding these enzymes
NO973685L (no) Multi-tumor avvikende vekstgener
EP1170992A4 (en) CLEANED AND ISOLATED GENES OF THE -I (PIWI) FAMILY, YOUR GENE PRODUCTS; AND METHOD FOR USE
WO1999051727A3 (de) Menschliche nukleinsäuresequenzen aus ovarnormalgewebe
FI940203A0 (fi) Geeni, joka koodaa eikosapeutaanihappoa syntetisoivia entsyymejä, ja menetelmä eikospentaanihapon valmistamiseksi
DE69534685D1 (de) Transferase und amylase, verfahren zur herstellung dieser enzyme, ihre verwendung und für die kodierende gene
AU2002365909A8 (en) Glycosidases, nucleic acids encoding them and methods of making and using them
IS5742A (is) Aðferð til genalækninga
NO20005587L (no) Genomiske sekvenser for produksjon og levering av protein
AU2002365188A8 (en) Nucleic acid delivery and expression
MX9806041A (es) Proteina purificada sr-p70.
NO20005585D0 (no) Genomiske sekvenser oppströms for den kodende regionen til IFN-ALPHA2 genet for produksjon og levering av protein
AU6795201A (en) Nucleic acid sequences and methods for the modification of plant gene expression
AU3937101A (en) Purified polynucleotide sequences of plants and yeast coding for proteins interacting with the products of geminivirus genome
ZA200005747B (en) Genomic sequences upstream of the coding region of the IFN-Alpha2 gene for protein production and delivery.
DE19983297T1 (de) Gene, die für beta-Agarasen kodieren, und ihre Verwendung zur Herstellung von Enzymen für den biologischen Abbau von Agar
HU0003279D0 (en) Process for preparation of metabolic products and nucleotide sequences encoding for the sod gene
EP1403373A4 (en) SAPONIN DIGESTIVE ENZYMES, GENES FOR THIS, AND A SOYASAPOGENOL B MASS PRODUCTION SYSTEM
EP1329504A4 (en) NUCLEIC ACID OF A NEW HUMAN GENE ASSOCIATED WITH KINESIN, PROTEIN ENCODED BY THIS NUCLEIC ACID, PEPTIDE FRAGMENT OF NUCLEIC ACID AND ANTICANCER AGENTS COMPRISING THE NUCLEIC ACID AND THE LIKE
EP1595955A4 (en) BETA 1,3-N-ACETYL-D-GALACTOSAMINE TRANSFERASE PROTEIN, NUCLEIC ACID ENCODING SAME, AND METHOD OF ANALYZING CANCERIZATION COMPRISING THE USE THEREOF
AU2000265672A1 (en) Somatic cloning gene transfer for the production of recombinant proteins, cells and organs

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application